Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Assmann

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Clinical Chemistry and Laboratory Medicine|July 9, 2008
PROCAM Study: risk prediction for myocardial infarction using microfluidic high-density lipoprotein (HDL) subfractionation is independent of HDL cholesterolOdilo Mueller, Elaine Chang, David Deng, et al.
Plos Genetics|May 20, 2006
Genome-wide mapping of susceptibility to coronary artery disease identifies a novel replicated locus on chromosome 17Martin Farrall, Fiona R Green, John F Peden, et al.
The Journal of Clinical Investigation|February 18, 2004
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3Jerzy-Roch Nofer, Markus van der Giet, Markus Tölle, et al.
The Journal of Biological Chemistry|April 7, 2004
Apolipoprotein A-I-stimulated apolipoprotein E secretion from human macrophages is independent of cholesterol effluxMaaike Kockx, Kerry-Anne Rye, Katharina Gaus, et al.
The American Journal of Cardiology|December 17, 2008
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemiaJean-Charles Fruchart, Frank Sacks, Michel P Hermans, et al.
Diabetes & Vascular Disease Research|October 30, 2008
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patientJean-Charles Fruchart, Frank M Sacks, Michel P Hermans, et al.
Cardiovascular Diabetology|January 28, 2014
Residual macrovascular risk in 2013: what have we learned?Jean-Charles Fruchart, Jean Davignon, Michel P Hermans, et al.
American Journal of Epidemiology|May 27, 2017
Use of Repeated Blood Pressure and Cholesterol Measurements to Improve Cardiovascular Disease Risk Prediction: An Individual-Participant-Data Meta-AnalysisEllie Paige, Jessica Barrett, Lisa Pennells, et al.
JAMA|July 17, 2012
Lipid-related markers and cardiovascular disease prediction, Emanuele Di Angelantonio, Pei Gao, et al.
Circulation|October 15, 2003
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part IIMorteza Naghavi, Peter Libby, Erling Falk, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Clinical Chemistry and Laboratory Medicine|July 9, 2008
PROCAM Study: risk prediction for myocardial infarction using microfluidic high-density lipoprotein (HDL) subfractionation is independent of HDL cholesterolOdilo Mueller, Elaine Chang, David Deng, et al.
Plos Genetics|May 20, 2006
Genome-wide mapping of susceptibility to coronary artery disease identifies a novel replicated locus on chromosome 17Martin Farrall, Fiona R Green, John F Peden, et al.
The Journal of Clinical Investigation|February 18, 2004
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3Jerzy-Roch Nofer, Markus van der Giet, Markus Tölle, et al.
The Journal of Biological Chemistry|April 7, 2004
Apolipoprotein A-I-stimulated apolipoprotein E secretion from human macrophages is independent of cholesterol effluxMaaike Kockx, Kerry-Anne Rye, Katharina Gaus, et al.
The American Journal of Cardiology|December 17, 2008
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemiaJean-Charles Fruchart, Frank Sacks, Michel P Hermans, et al.
Diabetes & Vascular Disease Research|October 30, 2008
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patientJean-Charles Fruchart, Frank M Sacks, Michel P Hermans, et al.
Cardiovascular Diabetology|January 28, 2014
Residual macrovascular risk in 2013: what have we learned?Jean-Charles Fruchart, Jean Davignon, Michel P Hermans, et al.
American Journal of Epidemiology|May 27, 2017
Use of Repeated Blood Pressure and Cholesterol Measurements to Improve Cardiovascular Disease Risk Prediction: An Individual-Participant-Data Meta-AnalysisEllie Paige, Jessica Barrett, Lisa Pennells, et al.
JAMA|July 17, 2012
Lipid-related markers and cardiovascular disease prediction, Emanuele Di Angelantonio, Pei Gao, et al.
Circulation|October 15, 2003
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part IIMorteza Naghavi, Peter Libby, Erling Falk, et al.
Pageof 9